Experimental vaccine can help delay IBD and colon cancer
An experimental vaccine against an abnormal protein found in some tumors has the potential to delay the onset of inflammatory bowel disease (IBD) and in turn prevent progression to colon cancer, according to researchers at the University of Pittsburgh School of Medicine.
Read more on News-Medical-Net
Ze-Guang Han and colleagues, at the Chinese National Human Genome Center at Shanghai, People’s Republic of China, have now identified SCARA5 as a candidate tumor suppressor gene in human hepatocellular carcinoma (HCC), a form of liver cancer that is the fifth most common cancer worldwide.
The research is reported in the Journal of Clinical Investigation.
» Read more: New Suppressor of Common Liver Cancer
Mutation quadruples repeat breast cancer risk
WASHINGTON, April 5 (Reuters) – Younger breast cancer patients who have a mutation in the well-known BRCA1 or BRCA2 genes are four times as likely to get cancer in the other breast as most patients, researchers reported on Monday.
Read more on AsiaOne